Considering the crucial role of LGALS3 in modulation of the bone tumor microenvironment and that bone metastases are a common clinical outcome of various solid cancers, the activities and mechanisms of other cancer‐derived LGALS3 underlying bone metastases are worthy of being further investigated. This evidence concerns the gene LGALS3 and cancer.